FGF21 and metabolic dysfunction-associated steatotic liver disease: HCHF- or HFD-induced ER stress and inflammation in WAT inhibit the browning process [226], inducing hypersecretion of FGF-21 leading to FGF-21 insensitivity and subsequently high levels, as observed in NAFLD and MetS patients [610, 611].